6,521,739 Shares DERMA SCIENCES, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • January 27th, 2014 • Derma Sciences, Inc. • Surgical & medical instruments & apparatus • New York
Derma Sciences, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto, for whom Piper Jaffray & Co. and Canaccord Genuity Inc. are acting as representatives (the “Representatives”), an aggregate of 6,521,739 shares (the “Firm Shares”) of common stock, $0.01 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 978,261 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Agreement are herein collectively called the “Securities.”
